iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for ion channel, Nav1.7 non-opioid analgesic, and the treatments for hearing loss and neurological diseases. iN Therapeutics has the world’s best ion channel evaluation platform and development know-how through developing a new drug targeting ion channel which is a promising target of various CNS (Central Nervous System) diseases for about 10 years.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 용인시, 경기도, Kr
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.intherapeutics.com
- Keywords
- 용인시.
- HQ
- 용인시, 경기도
In Therapeutics Questions
In Therapeutics's website is http://www.intherapeutics.com
In Therapeutics's LinkedIn profile is https://kr.linkedin.com/company/%EC%95%84%EC%9D%B4%EC%97%94%ED%85%8C%EB%9D%BC%ED%93%A8%ED%8B%B1%EC%8A%A4
In Therapeutics has
7 employees.
View email and phone details for 7
employees at In Therapeutics.
In Therapeutics's industry is
Research Services
In Therapeutics's top competitors are
Threebrooks Therapeutics Inc,
Kntec,
Lysoway Therapeutics,
Bring Out Inc.,
Nuvie Bio,
Patina,
Biospectator Inc.,
The Bio (더바이오),
Dandrite,
Hanken Business Lab.
In Therapeutics's categories are Research Services
In Therapeutics's founding year is 2020
